TVTXTravere Therapeutics, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $30.44 (+0.00% today)

Market Cap: $2.81B

P/E (TTM): -54.70

Forward P/E (FY1): 90.50

EPS Growth: 545.7%

Analyst Upside: 61.0%

Relative Strength (RS%): 1

-27.7% from 52-week high

Back to Scanner

TVTX

NASDAQRS 1Score 45

Travere Therapeutics, Inc.

HealthcareBiotechnology$2.81B3 setups passing
$30.44
0.0% ($0.00)
-27.7% from 52W High
P/E (TTM)
-54.70
Fwd P/E
90.50
PEG
0.57
Analyst Upside
+61.0%
EPS Growth
545.7%
Gross Margin
94.2%
ROE
-79.2%
D/E
2.96
Div Yield
0.0%
Avg Volume
1.1M

Price Chart

Key Levels

SMA 200
$26.43
SMA 50
$29.17
Price
$30.44
52W High
$42.10
Target
$49.00

Setup Radar

3/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst